Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 2, 2008 - Issue 3
Submit an article Journal homepage
96
Views
5
CrossRef citations to date
0
Altmetric
Review

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

Aldo M Roccaro1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USACorrespondence[email protected]
,
Irene M Ghobrial1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Simona Blotta1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Steven P Treon1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Michele Malagola2 Unit of Blood Diseases and Cell Therapies, University of Brescia Medical School, Brescia, Italy
,
Kenneth C Anderson1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
,
Paul G Richardson1 Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
&
Domenico Russo2 Unit of Blood Diseases and Cell Therapies, University of Brescia Medical School, Brescia, Italy
 show all
Pages 419-431 | Published online: 12 Sep 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Maria Paula Henao & Timothy J. Craig. (2016) Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency. Expert Review of Respiratory Medicine 10:12, pages 1281-1294.
Read now
Yotam Lior, Assaf Geyra & Eli C Lewis. (2016) Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 – 2015). Expert Opinion on Therapeutic Patents 26:5, pages 581-589.
Read now
Robert A. Sandhaus, James Stocks, Farshid N. Rouhani, Mark Brantly & Pnina Strauss. (2014) Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha1-Proteinase Inhibitor (Human), Intravenous). COPD: Journal of Chronic Obstructive Pulmonary Disease 11:1, pages 17-25.
Read now
F. Kueppers. (2011) The role of augmentation therapy in alpha-1 antitrypsin deficiency. Current Medical Research and Opinion 27:3, pages 579-588.
Read now

Articles from other publishers (1)

Prita R. Asih, Emmanuel Prikas, Kristie Stefanoska, Amanda R. P. Tan, Holly I. Ahel & Arne Ittner. (2020) Functions of p38 MAP Kinases in the Central Nervous System. Frontiers in Molecular Neuroscience 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.